Professional Documents
Culture Documents
DOI 10.1007/s11164-013-1259-0
Reda A. Haggam
Introduction
During the last few decades, the chemistry of 1,2,4-triazole and their fused
heterocyclic derivatives has received considerable attention due to their synthetic
and biological importance. The 1,2,4-triazole moieties have incorporated into
avariety of therapeutically interesting drug candidates involving antiviral (ribavarin)
and antimigraine (rizatriptan) [1–3]. Moreover, 4-amino-5-mercapto-1,2,4-triazole
derivatives possess comprehensive bioactivities such as antitumorial, antimicrobial,
anti-HIV and antibacterial activities [4–8]. 1,2,4-triazole-3-thiones and 2-amino-
1,3,4-thiadiazoles have been attracting considerable attention owing to their various
biological properties such as antioxidant [9, 10] and anticonvulsant [11–13]. The
synthetic nucleoside ribavirin, containing a 1,2,4-triazole ring, has become a unique
drug, when combined with the pegylated interferon-a, for the treatment of hepatitis
R. A. Haggam (&)
Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt
e-mail: rhaggam@yahoo.com
123
R. A. Haggam
Experimental
All experiments were carried out using drying solvents. Melting points were
determined on a Büchi melting point apparatus B-545 with open capillary tubes and
are uncorrected. Compounds were visualized with UV light (k = 254 nm). Products
were purified by recrystallization. IR spectra were measured on a Perkin-Elmer
Spectrum One (FT-IR-spectrometer). 1H, 13C NMR spectra were recorded on 300
(75) MHz on a Varian UnityInova spectrometer using DMSO as a solvent. The 1H
and 13C chemical shifts were referenced to residual solvent signals at dH/C 2.49/
39.50 (DMSO) relative to TMS as internal standards and coupling constant
(J) values are given in Hz. HSQC-, HMBC-, and COSY-spectra were recorded on a
Varian UnityInova at 300 MHz at HohenheimUniversity, Germany.
1,2-Bis-(4-amino-5-mercapto-4H-1,2,4-triazol-3-yl)benzene (3)
A mixture of phthalic acid (1) (10 mmol) and thiocarbohydrazide (2) (20 mmol) in
dry pyridine (10 mL) was heated under reflux for 4 h. The reaction mixture was
cooled and poured into ice-cold water. The formed product was filtered off, washed
with water and crystallized from ethanol/acetic acid (1:3) to give compound 3 in
93 % yield as white powder. Mp. 342–343 °C, IR (ATR): 3,360 cm-1 (NH2),
1,631 cm-1 (C=N), 1,600, 1,575, 1,547 cm-1 (C=C arom.). 1H NMR (300 MHz,
DMSO-d6): d = 7.87 (t, 1H, 3J = 7.6 Hz, 4J = 1.0 Hz, H-4), 7.96 (t, 1H,
3
J = 7.6 Hz, 4J = 1.0 Hz, H-5), 8.12 (d, 1H, 3J = 7.6 Hz, H-3), 8.24 (d, 1H,
3
J = 7.6 Hz, H-6), 14.32 (s, 2H, 2SH). 13C NMR (75 MHz, DMSO-d6): d = 120.2
(C-2), 122.5 (C-6), 123.6 (C-1), 125.7 (C-3), 132.0 (C-4), 133.9 (C-5), 140.3
(2NCS), 158.4, 161.2 (2NCN). Anal. Calcd for C10H10N8S2 (306.05): C, 39.20; H,
3.29; N, 36.57. Found: C, 39.17; H, 3.28; N, 36.51.
1,2-Bis-[4-amino-5-carboethoxymethylthio-4H-(1,2,4-triazol-3-yl)]-benzene (4)
Method A
To a solution of 3 (10 mmol) and anhydrous sodium acetate (20 mmol) in dry
ethanol (10 mL), ethyl bromoacetate (20 mmol) was added. The reaction mixture
123
Heterocyclization and functionalization
was heated under reflux for 6 h and then cooled. The formed precipitate was filtered
off, washed with ethanol, and then crystallized from ethanol to give compound 4 in
90 % yield as a yellow powder.
Method B
A solution of ethyl chloroacetate (20 mmol) in dry ethanol (10 mL) was added
dropwise to a solution of 3 (10 mmol) and 3 drops of triethylamine in dry ethanol
(10 mL). The mixture was heated under reflux for 6 h and then cooled. The formed
precipitate was filtered off, washed with ethanol and then crystallized from ethanol
to afford compound 4 in 91 % yield as yellow crystals. Mp. 221–222 °C, IR (ATR):
3,360 cm-1 (NH2), 1,631 cm-1 (C=N), 1,600, 1,575, 1,547 cm-1 (C=C arom.). 1H
NMR (300 MHz, DMSO-d6): d = 1.15 (t, 6H, 3J = 7.2 Hz, 2CH3), 4.12 (q, 4H,
3
J = 7.2 Hz, 2OCH2), 4.21 (s, 4H, 2SCH2), 7.89 (t, 1H, 3J = 7.6 Hz, H-4), 8.03 (t,
1H, 3J = 7.6 Hz, H-5), 8.20 (d, 1H, 3J = 7.6 Hz, H-3) 8.41 (d, 1H, 3J = 7.6 Hz,
H-6). 13C NMR (75 MHz, DMSO-d6): d = 14.6 (2CH3), 33.9 (2SCH2), 61.9
(2OCH2), 119.5 (C-2), 122.9 (C-6), 124.7 (C-1), 126.6 (C-3), 131.7 (C-4), 134.8
(C-5), 144.2, 144.4 (2NCN), 159.5 (2NCS), 169.0 (2C=O, ester). Anal. Calcd for
C18H22N8O4S2 (478.12): C, 45.18; H, 4.63; N, 23.42. Found: C, 45.10; H, 4.53; N,
23.39.
To a solution of 3 (10 mmol) in pyridine (10 mL), chloroacetyl chloride (20 mmol)
was added. The reaction mixture was heated under reflux for 2 h in oil bath and then
cooled. The mixture was poured into ice-cold water/hydrochloric acid with stirring.
The formed product was filtered off, washed with water, and then crystallized from
ethanol/dimethylformamide (1:1) to give compound 5 in 83 % yield as a faint
brown powder. Mp. 213–214 °C, IR (ATR): 3,260 cm-1 (NH), 1,593 cm-1 (C=N),
1,661 cm-1 (C=O). 1H NMR (300 MHz, DMSO-d6): d = 4.14 (s, 4H, 2SCH2),
7.91 (t, 1H, 3J = 7.6 Hz, H-4), 8.02 (t, 1H, 3J = 7.6 Hz, H-5), 8.19 (d, 1H,
3
J = 7.6 Hz, H-3) 8.41 (d, 1H, 3J = 7.6 Hz, H-6), 13.45 (br, 2H, 2NH).13C NMR
(75 MHz, DMSO-d6): d = 35.5 (2SCH2), 118.9 (C-2), 122.1 (C-6), 123.8 (C-2),
125.9 (C-3), 131.3 (C-4), 134.2 (C-5), 144.1, 143.5 (2NCN), 159.4 (2NCS), 169.6
(2C=O, amide). Anal. Calcd for C14H10N8O2S2 (386.04): C, 43.52; H, 2.61; N,
29.00. Found: C, 43.48; H, 2.57; N, 28.88.
1,2-Bis-[4-amino-5-carboxymethylthio-4H-1,2,4-triazol-3-yl]-benzene (8)
Method A
A mixture of 3 (10 mmol), chloroacetic acid (20 mmol) and potassium hydroxide
(20 mmol) in water (25 mL) was refluxed for 6 h. The solution was cooled, filtered,
and acidified with diluted hydrochloric acid. The formed precipitate was filtered off
and crystallized from ethanol/acetic acid (3:1) to give compound 8 in 81 % yield as
brown crystals.
123
R. A. Haggam
Method B
1,2-Bis[4-amino-5-bezoylmethylthio-4H-(1,2,4-triazol-3-yl)]-benzene (9)
Method A
To a solution of 3 (10 mmol) and anhydrous sodium acetate (2 mmol) in dry ethanol
(10 mL), phenacyl bromide (20 mmol) was added. The reaction mixture was heated
under reflux for 6 h and then cooled. The formed precipitate was filtered off, washed
with water and ethanol, and then crystallized from ethanol/acetic acid (1:2) to give
compound 9 in 83 % yield as a yellow powder.
Method B
A solution of phenacyl bromide (20 mmol) in dry ethanol (10 mL) was added
dropwise to a solution of 3 (10 mmol) and 5 drops of triethylamine in ethanol
(10 mL). The mixture was heated under reflux for 6 h and then cooled. The formed
precipitate was filtered off crystallized from ethanol/acetic acid (1:2) to afford
compound 9 in 88 % yield as yellow powder. Mp. 324–325 °C, IR (ATR):
1,676 cm-1 (C=O), 1,595 cm-1 (C=N). 1H NMR (300 MHz, DMSO-d6): d = 5.02
(s, 4H, 2SCH2), 7.52–7.57 (m, 6H, Ar–H), 7.66 (d, 4H, 3J = 7.2 Hz, Ar–H), 7.89
(t, 1H, 3J = 7.6 Hz, H-4), 8.01 (t, 1H, 3J = 7.6 Hz, H-5), 8.18 (d, 1H, 3J = 7.6 Hz,
H-3), 8.28 (s, 4H, NH2), 8.38 (d, 1H, 3J = 7.6 Hz, H-6). Anal. Calcd for
C26H22N8O2S2 (542.13): C, 57.55; H, 4.09; N, 20.65. Found: C, 57.51; H, 3.99; N,
20.53.
123
Heterocyclization and functionalization
1,2-Bis[4-amino-5-aminocarbonylmethylthio-4H-(1,2,4-triazol-3-yl)]-benzene
(11)
Yield: 87 %, pale yellow powder; Mp. 253–254 °C, IR (ATR): 3,458, 3,372,
3,347 cm-1 (2NH2), 1,684 cm-1 (C=O, amide), 1,669 cm-1 (C=N). 1H NMR
(300 MHz, DMSO-d6): d = 3.99 (s, 4H, 2SCH2), 7.22 (br s, 4H, 2NH2-N), 7.65 (br
s, 4H, 2NH2-C), 7.88 (t, 1H, 3J = 7.6 Hz, H-4), 8.01 (t, 1H, 3J = 7.6 Hz, H-5), 8.17
(d, 1H, 3J = 7.6 Hz, H-3), 8.38 (d, 1H, 3J = 7.6 Hz, H-6). 13C NMR (75 MHz,
DMSO-d6): d = 35.9 (2SCH2), 119.7 (C-2), 122.8 (C-6), 124.7 (C-1), 126.6 (C-3),
131.6 (C-4), 134.7 (C-5), 144.1, 145.1 (2NCN), 159.5 (2NCS), 169.6 (2C=O,
amide). Anal. Calcd for C14H16N10O2S2 (420.09): C, 39.99; H, 3.84; N, 33.31.
Found: C, 39.94; H, 3.71; N, 33.18.
1,2-Bis[4-amino-5-benzylthio-4H-(1,2,4-triazol-3-yl)]-benzene (13)
Yield: 97 %, yellow powder, Mp. 225–226 °C, IR (ATR): 1,660 cm-1 (C=N). 1H
NMR (300 MHz, DMSO-d6): d 4.52 (s, 4H, 2SCH2), 7.21–7.29 (m, 6H, Ar–H),
7.35 (d, 4H, 3J = 7.2 Hz, Ar–H), 7.86 (t, 1H, 3J = 7.6 Hz, H-4), 7.97 (t, 1H,
3
J = 7.6 Hz, H-5), 8.16 (d, 1H, 3J = 7.6 Hz, H-3), 8.38 (d, 1H, 3J = 7.6 Hz, H-6).
13
C NMR (75 MHz, DMSO-d6): d 35.3 (2SCH2), 118.8 (C-2), 122.1 (C-6), 124.0
(C-1), 125.8 (C-3), 127.4, 128.4, 128.9, 137.4 (2Ph), 130.7 (C-4), 134.0 (C-5), 143.4
and 144.1 (2NCN), 158.7 (2NCS). Anal. Calcd for C24H22N8S2 (486.14): C, 59.24;
H, 4.56; N, 23.03. Found: C, 59.22; H, 4.49; N, 22.87.
(1,2-Bis-[4-benzylideneamino-5-mercapto-1,2,4-triazol-3-yl]-benzene) (14a)
and (1,2-Bis-[5,6-dihydrophenyl-1,2,4-triazolo[3,4-b] [1,3,4] thiadiazol-3-yl]-
benzene) (14b)
Yield: 86 % in ratio 1:2 %, pale yellow powder; Mp. 322–323 °C, IR (ATR):
1,644 cm-1 (C=N), 1,628, 1,598 and 1,547 cm-1 (C=C arom.). 1H NMR
(300 MHz, DMSO-d6): d = 5.49 (s, 2H, 2HCNS), 7.35–7.61 (m, 8H, Ar–H),
7.88 (t, 1H, 3J = 7.6 Hz, H-4), 7.95 (t, 1H, 3J = 7.6 Hz, H-5), 8.14 (d, 1H,
3
J = 7.6 Hz, H-3), 8.25 (d, 1H, 3J = 7.6 Hz, H-6), 8.70, 10.64 (2S, 2H, 2HC=N,
syn and anti), 12.94 (br s, 2H, 2NH), 14.33 (br s, 2H, 2SH). Anal. Calcd for
123
R. A. Haggam
Yield: 79 %, pale yellow crystals; Mp. 213–214 °C, IR (ATR): 3,362 cm-1 (NH),
1,628 cm-1 (C=N). 1H NMR (300 MHz, DMSO-d6): d = 5.65 (s, 2H, 2HCNS),
7.79–7.84 (m, 8H, Ar–H), 8.32 (t, 1H, 3J = 7.8 Hz, H-4), 8.37 (t, 1H, 3J = 7.8 Hz,
H-5), 8.70 (d, 1H, 3J = 7.8 Hz, H-3), 8.90 (d, 1H, 3J = 7.8 Hz, H-6), 10.43 (s, 2H,
2NH). Anal. Calcd for C24H16N10O4S2 (572.08): C, 50.34; H, 2.82; N, 24.46.
Found: C, 50.31; H, 2.80; N, 24.52.
H H
4 5
H 6 H
3
H2N 2 1
NH2
N N
N N
HS N N SH
123
Heterocyclization and functionalization
COOH
COOH
1
+
S O H H O
N N
H2N NH2 N N
N N
H H N N
S N N S
2 5
pyridine
4 h, reflux
93%
O
H2N NH2
H2N NH2 X
O N N
N N O N N O
N N 6 h, reflux S S
HS N N
N N SH
O O
3 4
a: X = Br, NaOAc/EtOH, 90%
b: X = Cl, TEA/EtOH, 91%
O O
N N
N N
N N
S N N S
6
appear at d = 14.6, 61.9, and 33.9 ppm, respectively (Fig. 2). Also, the HSQC
spectrum revealed the carbons C-6, C-3, C-4, and C-5 at d = 122.8, 126.6, 131.7,
and 134.8 ppm, respectively.
The HMBC spectrum of compound 4 is used to determine the correlation
between the carbons and hydrogen atoms (Fig. 3). From the 13C NMR and HMBC
(Fig. 3) spectra, the proton 4-H displayed strong 3JCH correlations with C-2 at
d = 119.5 ppm and C-6 at d = 122.7 ppm. The proton 3-H showed strong 3JCH
correlations with C-1 at d = 124.7 ppm and C-5 at d = 134.8 ppm. Its 13C NMR
spectrum showed a signal at d 169.0 ppm corresponding to 2C=O groups and two
signals at d 144.2, 144.4 ppm for unsymmetrical 2NCN, while one signal at d
159.5 ppm was for symmetrical 2NCS groups. The 1H NMR spectrum of 4
displayed only half of the expected number of signals for the two triazole rings, but
all the expected numbers of signals for the phenyl group, indicating that the triazole
substituents are symmetrical and that it is non-planer compound.
Heating of compound 3 with chloroacetyl chloride under reflux for 2 h in an oil
bath in the presence of pyridine afforded triazolothiadiazinone 5 in 83 % yield. On
the other hand, if the reaction was carried out in acetone at room temperature for
24 h, no reaction product was obtained, but starting materials were obtained.
123
R. A. Haggam
123
Heterocyclization and functionalization
H H
4 5
H 6 H
3
H2N 2 1
NH2
N N
H3C O CH3
N N O
S N N S
O O
4
at d 4.17 ppm as singlet, indicating that S-alkylation took place. There is another
singlet at d 8.32 ppm characteristic for 2NH2 protons. We can deduce that both 3-H
and 4-H protons are beside each other and also 5-H and 6-H. The HSQC spectrum
(Fig. 4) revealed the carbon atoms C-6, C-3, C-4, C-5, and SCH2 at d = 122.1,
125.8, 130.9, 134.0, and 33.4 ppm, respectively.
The 13C NMR and HMBC spectra of compound 8 (Fig. 5) demonstrated that the
proton 6-H exhibited strong 3JCH correlations with C-2 at d = 118.8 ppm, C-4 at
d = 130.9 ppm, and NCN at d = 143.4 ppm. The proton 3-H showed strong 3JCH
correlations with C-1 at d = 123.9 ppm and C-5 at d = 134.0 ppm. Its 13C NMR
spectrum showed a characteristic signal at d 169.6 ppm corresponding to 2C=O
groups. Moreover, no signals corresponding to the NH groups were found in the
spectrum, confirming that the triazolothiadiazinone 5 was not formed. The
elemental analysis of compound 8 is in agreement with its structure.
The aminomercaptotriazole 3 was refluxed with phenacyl bromide under basic
conditions in dry ethanol and anhydrous sodium acetate or triethylamine to yield the
benzoylmethylthiotriazole derivative 9 in good yield, but not the triazolothiadiazine
10. On heating 9 with acetic acid, the reaction did not also form compound 10. The
structure of compound 9 was established by its analysis and spectral data. The IR
spectrum of 9 exhibited a band at 1,676 cm-1 for the C=O group, indicating that the
triazolothiadiazine 10 was not formed (Scheme 3).
Treatment of 3 with chloroacetamide or benzyl chloride in the presence of a few
drops of triethylamine in ethanol under reflux for 1–3 h afforded the compounds 11
123
R. A. Haggam
O H H O
H2N NH2 N N
Cl N N N N
Cl
N N N N
S N N S S N N S
O O
7 5
O
Cl
Cl
pyridine
2 h, oil bath
O
H2N NH2 Cl H2N NH2
N N OH N N
HO N N OH
N N 6 h, reflux
HS N N SH S N N S
TEA/EtOH 84% O
KOH/H2O 81% O
3 8
O
Cl
Cl
acetone, r.t
stirring 24 h
No rea.
Scheme 2 Reaction of the aminomeraptotriazole 3 with both chloroacetyl chloride and chloro acetic acid
and 13 but not 12. In addition, refluxing compound 11 with acetic acid,
triazolothiadiazine 12 was not obtained (Scheme 4).
The IR spectrum of 13 displayed a band at 1,660 cm-1 for the C=N group. In the
13
C NMR and HMBC spectra of 13, the proton 4-H exhibited strong 3JCH
correlations with C-2 at d = 118.8 ppm and C-6 at d = 122.1 ppm. The proton 3-H
showed strong 3JCH correlations with C-1 at d = 124.0 ppm and C-5 at
d = 133.9 ppm.
123
Heterocyclization and functionalization
H H
4 5
H 6 H
3
H2N 2 1
NH2
N N
N N
S N N S
13
H H
4 5
H 6 H
3
H2N 2 1
NH2
N N
HO N N OH
S N N S
O O
8
123
R. A. Haggam
H2N NH2
N N
Ph N N Ph
S N N S
O O
9
O
H2N NH2 Cl AcOH
N N Ph 4 h, reflux
N N EtOH, 6 h, reflux
HS N N SH
3 a: TEA 88%
b: NaOAc 83%
Ph Ph
N N
N N
N N
S N N S
10
Scheme 3 Reaction of the aminomercaptotriazole 3 with phenacyl chloride under different reaction
conditions
Cl
O
H2N NH2 Cl H2N NH2
N N NH2 N N
N N TEA, EtOH H2N N N NH2
HS N N SH 3 h, reflux S N N S
O O
3 11
123
Heterocyclization and functionalization
O2N NO2
H H H H
N N H H H H
N N N N
N N
S N N
S S N N
N N S
N N
15 14b
CHO
EtOH/AcOH
2 4 h reflux
NO2
CHO
H2N NH2 N N
N N EtOH/AcOH
3 h reflux N N
N N + 2 N N
HS N N SH HS N SH
N
3 14a
Conclusion
References
1. B.S. Holla, B. Veerendra, M.K. Shivananda, B. Poojary, Eur. J. Med. Chem. 759, 38 (2003)
2. J. Wu, X. Liu, X. Cheng, Y. Cao, D. Wang, Z. Li, Molecules 2003, 12 (2007)
3. S. Jubie, P. Sikdar, S. Antony, R. Kalirajan, B. Gowramma, S. Gomathy, K. Elango, Pak. J. Pharm.
Sci. 109, 24 (2011)
4. N. Demirbas, U.A. Demirbas, Bioorg. Med. Chem. 3717, 10 (2002)
5. N.N. Gulerman, H.N. Dogan, S. Rollas, C. Johansson, C.C. Elik, Farmaco 953, 56 (2001)
6. A.R. Farghaly, E. Declerk, H. Elkashef, Arkivoc 137, x, (2006)
7. S. Kiran, B.M. Singh, T. Parikshit, Eur. J. Med. Chem. 147, 41 (2006)
8. L.G. Almajan, I. Saramet, S.F. Barbuceanu, C. Draghici, G. Bancescu, Rev. Chem. (Bucharest) 896,
60 (2009)
123
R. A. Haggam
9. I. Khan, S. Ali, S. Hameed, N.H. Rama, M.T. Hussain, A. Wadood, R. Uddin, Z. Ul-Haq, A. Khan,
S. Ali, M.I. Choudhary, Eur. J. Med. Chem. 5200, 45 (2010)
10. G. Ayhankilcigil, C. Kus, T. Çoban, B. Caneke, M. Iscan, J. Enz, Inhib. Med. Chem. 129, 19 (2004)
11. H.N. Dogan, A. Duran, S. Rollas, G. Sener, M.K. Uysal, D. Gülen, Bioorg. Med. Chem. 2893, 10
(2002)
12. R. Sharma, G.P. Misra, J. Sainy, S.C. Chaturvedi, Med. Chem. Res. 245, 20 (2011)
13. S.F. Barbuceanu, G. Saramet, G.L. Almajan, C. Draghici, F. Barbuceanu, G. Bancescu, Eur. J. Med.
Chem. 417, 49 (2012)
14. B.W. Dymock, P.S. Jones, F.X. Wilson, Antivir. Chem. Chemother. 79, 11 (2000)
15. L.F. Awad, E.S.H. El Ashry, Carbohydr. Res. 9, 312 (1998)
16. E.S.H. El Ashry, L.F. Awad, Nucleosides Nucleotides Nucleic Acids 901, 20 (2001)
17. E.S.H. El Ashry, L.F. Awad, Nucleosides Nucleotides Nucleic Acids 103, 20 (2001)
18. A.H. Moustafa, R.A. Haggam, M.E. Younes, E.S.H. El Ashry, Nucleosides Nucleotides Nucleic
Acids 1885, 24 (2005)
19. A.H. Moustafa, R.A. Haggam, M.E. Younes, E.S.H. El Ashry, Phosphorus Sulfur Silicon 2361, 181
(2006)
123